NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathwaysNaze G. Avci(University of Houston), Metin Akay(University of Houston)Scientific ReportsAugust 7, 202010.1038/s41598-020-70392-5Cited by 84SaveCiteExport RISWatch citationsRelated PapersMiR 329/449 Suppresses Cell Proliferation, Migration and Synergistically Sensitize GBM to TMZ by Inhibiting Src/FAK, NF-kB, and Cyclin D1 Activity|Preprints.org|2025|1